Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories - Scorecard - MDSpire

Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories

  • By

  • Maxime Pichon

  • Claire Bouleti

  • MICMAC Study Group SFM

  • Genevieve Hery-Arnaud

  • Christophe Burucoa

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Variability and Absence of Standardization in Gut Microbiome Testing: A Comparative Analysis of Medical Biology Laboratories in France

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients seeking microbiome analysis without prior consultation or guidance.
Care Setting

Key Highlights

  • Add examples of health risks and conflicts of interest.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regular evaluation of microbiome testing methods and results is necessary, ideally every 6-12 months.

      Risks

        Patient & Prescribing Data

        Health recommendations from tests are often non-personalized and unsubstantiated, potentially leading to misinformed health decisions.

        Clinical Best Practices

        • Integrate microbiome considerations into clinical practice through training and resources.
        • Enhance transparency and clinical validation of microbiome tests by publishing methodologies.
        • Foster collaboration between regulators, industry, and academia to establish best practices.

        Related Resources & Content

        Original Source(s)

        Related Content